Long-term research is lacking – potential harm remains unclear – valid studies are urgently needed for growing and developing children and adolescents Due to a lack of suitable studies, it remains unclear whether children and adolescents with type 1 diabetes benefit more or less from long-term treatment with rapid-acting insulin analogues than with short-acting human insulin. Certainly, there is no proof of additional benefit from the available results from clinical trials of maximum one year duration…

Read more from the original source: 
Rapid-Acting Insulin Analogues: Trials Provide No Proof Of Additional Benefit For Children And Adolescents With Type 1 Diabetes

Related posts:

1. Cardiovascular Risk In Youth With Type 1 Diabetes Linked Primarily To Insulin ResistanceAccording to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM), youth with type 1 diabetes have now been found to have...
2. Biovitrum Advances Novel Factor VIII Long-Acting Hemophilia A Therapy Into Clinical TrialsBiovitrum AB (publ) (STO: BVT) announced that the first patient was dosed in a phase I/IIa study of its long-acting fully-recombinant Factor VIII Fc fusion (rFVIIIFc) protein. The phase I/IIa...
3. Risk For Obstructive Sleep Apnea Increased By Obesity In Adolescents, But Not In Younger ChildrenA study in the Dec. 15 issue of the Journal of Clinical Sleep Medicine shows that being overweight or obese increases the risk for developing obstructive sleep apnea (OSA) in...
4. Type 2 Diabetes Gene Predisposes Children To ObesityPediatric researchers have found that a gene already implicated in the development of type 2 diabetes in adults also raises the risk of being overweight during childhood. The finding sheds...
5. UNC Scientists Coordinate Study To Determine Link Between Insulin Use And Cancer In People With DiabetesType 2 diabetes and obesity are linked to an increased risk of certain cancers. Recently published studies suggested that insulin glargine (a synthetic insulin preparation marketed under the trade name...
6. Four New Research Projects Announced – Diabetes UKDiabetes UK has dedicated almost £750,000 to four new research projects looking to understand the causes of diabetes, help with its day-to-day management and protect against its complications. All four...
7. Discovery Of Mechanism Of Insulin Production May Lead To Better Treatment For DiabetesHow a specific gene within the pancreas affects secretion of insulin has been discovered by researchers from the Hebrew University of Jerusalem, in collaboration with Japanese and American universities. Their...
8. Echo Therapeutics Announces Positive Results Of A Clinical Study Testing Symphony(TM) TCGM System In Patients With Type 1 And Type 2 DiabetesEcho Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing its needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System...
9. Two Thirds Of Brits Do Not Know The Difference Between Type 1 And Type 2 DiabetesNew research out today reveals that less than a third of UK residents (30 per cent) know of type 1 diabetes with a further 59 per cent confusing the autoimmune...
10. U.S. Clinical Trials Show Single Dose Of H1N1 Vaccine Protects Pregnant Women, Children Under 10 Need Two DosesU.S. government data released on Monday confirmed that a single dose of the vaccine protects pregnant women from the virus, while children under the age of 10 years need two...
11. Stay-Tabs On Beverage Cans Pose Swallowing Risk To Children And AdolescentsThree decades ago, a study revealed that beverage can pull-tabs were being swallowed by children, prompting a switch by U.S. manufacturers to stay-tabs. But a study presented at the annual...
12. FDA Approved Drug May Slow Beta Cell Destruction In Type 1 Diabetes PatientsNew findings by UT Southwestern researchers suggest that a drug already used to treat autoimmune disorders might also help slow the destruction of insulin-producing cells in patients recently diagnosed with...
13. What is the history and Origin of Type 2 Diabetes?Diabetes has been one of the most shattering diseases known to man, and it has been acknowledged for over two thousand years, but there is no account of type 2...
14. New Type 2 Diabetes And Obesity Treatment Approved – EndoBarrier Receives European CE MarkGI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced that it has received European CE mark approval for the EndoBarrier(TM), a non-surgical therapy...
15. What Are The Different Type Of Diabetes?Diabetes mellitus mainly comes when pancreas does not produce in sufficient amounts or any of hormone insulin or when insulin is generated that does not perform out efficiently....